UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038126
Receipt number R000043453
Scientific Title Examination of airway management method in intravenous anesthesia using Nasal High
Date of disclosure of the study information 2019/10/09
Last modified on 2021/09/28 09:08:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of airway management method in intravenous anesthesia using Nasal High Flow load device AIRVO

Acronym

Examination of airway management method in intravenous anesthesia using Nasal High Flow

Scientific Title

Examination of airway management method in intravenous anesthesia using Nasal High

Scientific Title:Acronym

Examination of airway management method in intravenous anesthesia using Nasal High Flow

Region

Japan


Condition

Condition

intravenous anesthesia

Classification by specialty

Anesthesiology Dental medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Elucidate how Nasal High Flow high-flow air load device improves respiratory function and how salivary swallowing function is affected by upper airway obstruction during intravenous anesthesia

Basic objectives2

Others

Basic objectives -Others

The Nasal High Flow loading device, which flows air at a high flow rate from the nasal cavity, has been reported to improve respiratory function during intravenous anesthesia due to mild positive pressure load (several cmH2O) and decreased rebreathing. It is also starting to be applied to management. However, there are no studies that have examined the effectiveness of Nasal High Flow for upper airway obstruction during anesthesia, and it is not clear how it affects salivary swallowing function. In this study, we will elucidate the mechanism by which a high-flow air load device improves upper airway obstruction that occurs during anesthesia and during anesthesia awakening, and how much the salivary swallowing function is affected.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Upper airway patency

Key secondary outcomes

Saliva swallowing function


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Device,equipment

Interventions/Control_1

propofol

Interventions/Control_2

Dexmedetomidine

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Targeting healthy adult subjects (volunteers) who agree with the explanation of the contents of the research plan.

Key exclusion criteria

1) Patients with severe respiratory illness
2) Patients with serious cardiovascular disease
3) Diabetes patients with poor control
4) Severe kidney injury patients
5) Patients with severe liver damage
6) Patients with hypersensitivity (allergy) to the drug to be used
7) Patients who are judged inappropriate by the research supervisor or research supervisor

Target sample size

50


Research contact person

Name of lead principal investigator

1st name TAKAO
Middle name
Last name AYUSE

Organization

Nagasaki University

Division name

Dental Anesthesia

Zip code

8528588

Address

1-7-1 Sakamoto Nagasaki

TEL

0958197713

Email

ayuse@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name TAKAO
Middle name
Last name AYUSE

Organization

Nagasaki University Hospital

Division name

Dental Anesthesia

Zip code

8528588

Address

1-7-1 Sakamoto Nagasaki

TEL

0958197713

Homepage URL


Email

ayuse@nagasaki-u.ac.jp


Sponsor or person

Institute

Nagasaki University

Institute

Department

Personal name



Funding Source

Organization

Nagasaki Universuty

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki University Graduate School of Biomedical Sciences (Dental Science) Ethics Committee

Address

1-7-1 Sakamoto Nagasaki

Tel

0958197177

Email

ayuse@nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 10 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 03 Month 09 Day

Date of IRB

2019 Year 03 Month 09 Day

Anticipated trial start date

2019 Year 10 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry

2022 Year 04 Month 30 Day

Date trial data considered complete

2022 Year 05 Month 30 Day

Date analysis concluded

2022 Year 06 Month 15 Day


Other

Other related information



Management information

Registered date

2019 Year 09 Month 27 Day

Last modified on

2021 Year 09 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043453


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name